| 
  • If you are citizen of an European Union member nation, you may not use this service unless you are at least 16 years old.

  • You already know Dokkio is an AI-powered assistant to organize & manage your digital files & messages. Very soon, Dokkio will support Outlook as well as One Drive. Check it out today!

View
 

DIYgenomics

This version was saved 14 years, 2 months ago View current version     Page history
Saved by Administrator
on February 7, 2010 at 11:12:38 am
 

DIYgenomics - the Citizen Genomes Project

Back to the main Open Thought Space

 

DIYgenomics citizen science experiments

  • Direct-to-consumer genomics SNP/locus comparison by condition
  • Replicate, extend and develop new studies linking genotype with phenotype/behavior
    • MTHFR mutation, Vitamin B12 deficiency
    • Are you a bad driver? Examine BDNF genotypes and driving records
    • Determine the SNP and genotype profile for Viagra metabolism
    • APOE4 genotyping together with mid-life cholesterol management programs
    • Novelty seeking genotypes together with behavioral data
    • Apply SNP values from the Boston University centenarian study to corresponding phenotypic markers of aging
    • Apply genotype/pharmacogenomic associations found in the PharmGKB database
    • Tie certain genotyping data to environmental data: toxins, stress, etc.
  • Apply traditonal economic/financial risk models to multigenic disease risk prediction
  • Assemble a list of core SNPs/loci that should be reviewed in any genomics disease analysis

DIYgenomics citizen science ethics and standards

  • Citizen science analog of an IRB (institutional review board)/ethics committee for human biomedical research
  • Standards development for citizen science
    • Standard means of citizen participation (e.g.; question posing forums)
    • Particpant acknowledgement: Anonymous,Nonanonymous
    • Nomenclature

 

Personal Genome Analysis Startups

 

Open science resources

 

 

Back to the main MS Futures Group website

 

Contact: m AT melanieswan.com

 

Comments (0)

You don't have permission to comment on this page.